Economic analysis for evidence-based policy-making on a national immunization program: A case of rotavirus vaccine in Thailand

Vaccine

Volumn 30, Issue 18, 2012, Pages 2839-2847

  Muangchana, Charung ^a   Riewpaiboon, Arthorn ^b   Jiamsiri, Suchada ^a   Thamapornpilas, Piyanit ^a   Warinsatian, Porpit ^a  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cost effectiveness analysis; Economic analysis; National immunization program; Rotavirus; Thailand; Vaccine

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; BUDGET; CHILD; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG COST; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROBABILITY; ROTAVIRUS DIARRHEA; SENSITIVITY ANALYSIS; THAILAND; VACCINATION;

CHILD, PRESCHOOL; COSTS AND COST ANALYSIS; DIARRHEA; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; POLICY MAKING; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; THAILAND;

EID: 84859005282     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.02.047     Document Type: Article

References (74)

1. World Health Organization Western Pacific Region. Rotavirus Bulletin 2009;1(1). 2010 [cited 2010 September 2]; Available from: http://www.wpro.who.int/sites/epi/documents/RotavirusBulletin.htm.
2. Soares-Weiser K., Maclehose H., Ben-Aharon I., Goldberg E., Pitan F., Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2010, 5:CD008521.
3. World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 2007;82(32):285-96.
4. Newall A.T., Beutels P., Macartney K., Wood J., MacIntyre CR The cost-effectiveness of rotavirus vaccination in Australia. Vaccine 2007, 25(52):8851-8860. [Epub 2007, October 23].
5. Constenla D.O., Linhares A.C., Rheingans R.D., Antil L.R., Waldman E.A., da Silva L.J. Economic impact of a rotavirus vaccine in Brazil. J Health Popul Nutr 2008, 26(December (4)):388-396.
6. de Soarez P.C., Valentim J., Sartori A.M., Novaes H.M. Cost-effectiveness analysis of routine rotavirus vaccination in Brazil. Rev Panam Salud Publica 2008, 23(April (4)):221-230.
7. Constenla D., O'Ryan M., Navarrete M.S., Antil L., Rheingans RD [Potential cost effectiveness of a rotavirus vaccine in Chile]. Rev Med Chil 2006, 134(6):679-688. [Epub 2006, August 14].
8. Wang X.Y., Riewpaiboon A., von Seidlein L., Chen X.B., Kilgore P.E., Ma J.C., et al. Potential cost-effectiveness of a rotavirus immunization program in rural China. Clin Infect Dis 2009, 49(October (8)):1202-1210.
9. De la Hoz F., Alvis N., Narvaez J., Cediel N., Gamboa O., Velandia M. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia. Vaccine 2010, 28(May (22)):3856-3864.
10. Ortega O., El-Sayed N., Sanders J.W., Abd-Rabou Z., Antil L., Bresee J., et al. Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt. J Infect Dis 2009, 200(November (Suppl. 1)):S92-S98.
11. Rose J., Hawthorn R.L., Watts B., Singer M.E. Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis. BMJ 2009, 339:b3653.
12. Wilopo S.A., Kilgore P., Kosen S., Soenarto Y., Aminah S., Cahyono A., et al. Economic evaluation of a routine rotavirus vaccination programme in Indonesia. Vaccine 2009, 27(November (Suppl. 5)):F67-F74.
13. Flem E.T., Kasymbekova K.T., Vainio K., Gentsch J., Abdikarimov S.T., Glass R.I., et al. Rotavirus infection in hospitalized children and estimates of disease burden in Kyrgyzstan, 2005-2007. Vaccine 2009, 27(November (Suppl. 5)):F35-F39.
14. Tate J.E., Rheingans R.D., O'Reilly C.E., Obonyo B., Burton D.C., Tornheim J.A., et al. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in Kenya. J Infect Dis 2009, 200(November (Suppl. 1)):S76-S84.
15. Valencia-Mendoza A., Bertozzi S.M., Gutierrez J.P., Itzler R. Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico. BMC Infect Dis 2008, 8:103.
16. Milne R.J., Grimwood K. Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule. Value Health 2009, 12(September (6)):888-898.
17. Wu C.L., Yang Y.C., Huang L.M., Chen K.T. Cost-effectiveness of childhood rotavirus vaccination in Taiwan. Vaccine 2009, 27(March (10)):1492-1499.
18. Chotivitayatarakorn P., Poovorawan Y. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children. Southeast Asian J Trop Med Public Health 2010, 41(January (1)):114-125.
19. Isakbaeva E.T., Musabaev E., Antil L., Rheingans R., Juraev R., Glass R.I., et al. Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine. Vaccine 2007, 25(2):373-380. [Epub 2006, August 2].
20. Weycker D., Sofrygin O., Kemner J.E., Pelton S.I., Oster G. Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq. Vaccine 2009, 27(August (6)):4930-4937.
21. Tucker A.W., Haddix A.C., Bresee J.S., Holman R.C., Parashar U.D., Glass R.I. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 1998, 279(17):1371-1376.
22. Widdowson M.A., Meltzer M.I., Zhang X., Bresee J.S., Parashar U.D., Glass R.I. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 2007, 119(4):684-697.
23. Fischer T.K., Anh D.D., Antil L., Cat N.D., Kilgore P.E., Thiem V.D., et al. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 2005, 192(10):1720-1726.
24. Kim S.Y., Goldie S.J., Salomon J.A. Cost-effectiveness of Rotavirus vaccination in Vietnam. BMC Public Health 2009, 9:29.
25. Rheingans R.D., Constenla D., Antil L., Innis B.L., Breuer T. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Rev Panam Salud Publica 2007, 21(4):205-216.
26. Podewils L.J., Antil L., Hummelman E., Bresee J., Parashar U.D., Rheingans R. Projected cost-effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 2005, 192(Suppl. 1):S133-S145.
27. Rheingans R.D., Constenla D., Antil L., Innis B.L., Breuer T. Economic and health burden of rotavirus gastroenteritis for the 2003 birth cohort in eight Latin American and Caribbean countries. Rev Panam Salud Publica 2007, 21(4):192-204.
28. Steele A.D., Patel M., Parashar U.D., Victor J.C., Aguado T., Neuzil K.M. Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a world health organization-sponsored consultation. J Infect Dis 2009, 200(November (Suppl. 1)):S63-S69.
29. Rheingans R.D., Antil L., Dreibelbis R., Podewils L.J., Bresee J.S., Parashar U.D. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. J Infect Dis 2009, 200(November (Suppl. 1)):S16-S27.
30. Atherly D., Dreibelbis R., Parashar U.D., Levin C., Wecker J., Rheingans R.D. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries. J Infect Dis 2009, 200(November (Suppl. 1)):S28-S38.
31. Santosham M., Nelson E.A., Bresee J.S. Implementing rotavirus vaccination in Asia. Vaccine 2007, 25(November (44)):7711-7716.
32. Jit M., Bilcke J., Mangen M.J., Salo H., Melliez H., Edmunds W.J., et al. The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe. Vaccine 2009, 27(October (44)):6121-6128.
33. Personal communication with OPTIMIZE staff. Rotavirus vaccine in the NIP; 2010.
34. Muangchana C., Thamapornpilas P., Karnkawinpong O. Immunization policy development in Thailand: The role of the Advisory Committee on Immunization Practice. Vaccine 2010, 28S:A104-A109.
35. Personal communication with GSK staff. Rotavirus vaccination in Thailand from IMS data adjusted with GSK internal data. Bangkok; 2009.
36. Torrance G.W., Siegel J.E., Luce B.R. Framing and designing the cost effectiveness analysis. Cost-effectiveness in health and medicine 1996, Oxford University Press, Oxford. M.R. Gold, J.E. Sigel, L.B. Russell, M.C. Weinstein (Eds.).
37. Briggs A., Sculpher M., Claxton K. Decision modelling for health economic evaluation 2006, Oxford University Press, New York.
38. Jiraphongsa C., Bresee J.S., Pongsuwanna Y., Kluabwang P., Poonawagul U., Arporntip P., et al. Hospital-based surveillance of rotavirus diarrhea in children less than 5 years old in Thailand Nonthaburi: Bureau of Epidemiology 2005, Ministry of Public Health, Nonthaburi, Thailand.
39. Pirunjindarat C., Pinprachanunt V., Pongsuchat S., Jansawang S., Wetsutthanon K., Tharmaphornpilas P. Incidence of acute diarrhea and rotavirus infection in community, Huai Krachao District, Kanchanaburi 2001-2002 (in Thai language). J Health Sci 2003, 12:983-989.
40. Jiraphongsa C., Bresee J.S., Pongsuwanna Y., Kluabwang P., Poonawagul U., Arporntip P., et al. Epidemiology and burden of rotavirus diarrhea in Thailand: results of sentinel surveillance. J Infect Dis 2005, 192(September (Suppl. 1)):S87-S93.
41. Kim J.S., Kang J.O., Cho S.C., Jang Y.T., Min S.A., Park T.H., et al. Epidemiological profile of rotavirus infection in the Republic of Korea: results from prospective surveillance in the Jeongeub District, 1 July 2002 through 30 June 2004. J Infect Dis 2005, 192(September (Suppl. 1)):S49-S56.
42. Jiraphongsa C., Laosiritaworn Y., Ngowabunpat A. Diarrhea mortality in children 0-5 years old in Thailand, 2001-2004. Bull Dept Med Sci 2005, 30(2):43-51.
43. Van Man N., Luan le T., Trach D.D., Thanh N.T., Van Tu P., Long N.T., et al. Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003. J Infect Dis 2005, 192(September (Suppl. 1)):S127-S132.
44. Zaman K., Anh D.D., Victor J.C., Shin S., Yunus M., Dallas M.J., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376(August (9741)):615-623.
45. Linhares A.C., Velazquez F.R., Perez-Schael I., Saez-Llorens X., Abate H., Espinoza F., et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008, 371(April (9619)):1181-1189.
46. Phua K.B., Lim F.S., Lau Y.L., Nelson E.A., Huang L.M., Quak S.H., et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine 2009, 27(October (43)):5936-5941.
47. Goveia M.G., Suprun L., Itzler R.F., McFetridge R., Dallas M.J., Kuter B.J. Efficacy and safety of pentavalent human-bovine reassortant rotavirus vaccine when administered with greater than 10 weeks between doses. Pediatr Infect Dis J 2010, 29(March (3)):263-265.
48. Vesikari T., Itzler R., Karvonen A., Korhonen T., Van Damme P., Behre U., et al. RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe. Vaccine 2009, 28(December (2)):345-351.
49. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(January (1)):23-33.
50. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354(January (1)):11-22.
51. Tharmaphornpilas P, Rasdjarmrearnsook A. A survey of EPI vaccination coverage among school children 2008 (in Thai language). Nonthaburi: Bureau of General Communicable Diseases, Department of Disease Control, Ministry of Public Health; 2009.
52. Kobelt G. Health economics: an introduction to economic evaluation. Second ed. London: Office of Health Economics; 2002.
53. Riewpaiboon A., Sooksriwong C., Rookkapan K., Chaiyakunapruk N., Tharmaphornpilas P., Techathawat S., et al. Vaccine supply chain and logistics system in Thailand 2011, Faculty of Pharmacy Mahidol University, Bangkok.
54. Office of the National Economic and Social Development Board. National income of Thailand. 2009 edition [cited 2010 October 20]; Available from: http://www.nesdb.go.th/Default.aspx%3Ftabid=94.
55. Edejer T.T.-T., Baltussen R., Adam T., Hutubessy R., Acharya A., Evans D.B., et al. Making choices in health: WHO guide to cost-effectiveness analysis 2003, World Health Organization, Geneva.
56. Murray C.J. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 1994, 72(3):429-445.
57. The Thai Working Group on Burden of Disease and Injuries. Burden of disease and injuries in Thailand; priority setting for policy. Nonthaburi: Bureau of Health Policy and Planning, Ministry of Public Health, 2002.
58. Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B.J., Stoddart G.L. Methods for the economic evaluation of health care programmes third edition 2005, Oxford University Press, Oxford. second ed.
59. Luce B.R., Manning W.G., Siegel J.E., Lipscomb J. Estimating costs in cost-effectiveness analysis. Cost-effectiveness in health and medicine 1996, Oxford University Press, Oxford. M.R. Gold, J.E. Sigel, L.B. Russell, M.C. Weinstein (Eds.).
60. World Health Organization. The world health report 2002-Reducing risks, promoting healthy life. Geneva: World Health Organization; 2002.
61. Department of Disease Control. Evaluation of prevention and control for acute respiratory tract infection and diarrhoea among children aged under 5 years old in community in 2005 (in Thai language). Nonthaburi: Department of Disease Control; 2005.
62. Bank of Thailand. Rates of Exchange of Commercial Banks in Bangkok Metropolis 2009 [cited 2011 February 19]; Available from: http://www2.bot.or.th/statistics/ReportPage.aspx%3FreportID=123%26language=eng.
63. Riewpaiboon A., Intraprakan K., Phoungkatesunthorn S. Predicting treatment cost for bacterial diarrhoea at a regional hospital in Thailand. J Health Popul Nutr 2008, 26(4):442-450.
64. Riewpaiboon A. Standard cost list for health technology assessment. Nonthaburi: Health Intervention and Technology Assessment Program, Ministry of Public Health; 2011.
65. Bureau of Epidemiology Department of Disease Control Ministry of Public Health. Reported cases by place of treatment, Thailand, 2009 [cited 2011 May 16]; Available from: http://epid.moph.go.th/Annual/Annual%202552/Main.html.
66. Ministry of Commerce. Report for consumer price index of Thailand [cited 2011 February 19]; Available from: http://www.indexpr.moc.go.th/price_present/TableIndexG_region_y.asp%3Fyear_base=2550%26province_code=5.
67. Parashar U.D., Burton A., Lanata C., Boschi-Pinto C., Shibuya K., Steele D., et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009, 200(November (Suppl. 1)):S9-S15.
68. Nelson E.A., Bresee J.S., Parashar U.D., Widdowson M.A., Glass R.I. Rotavirus epidemiology: the Asian Rotavirus Surveillance Network. Vaccine 2008, 26(June (26)):3192-3196.
69. Plaitho J., Poonawakool U. Household resource affected by acute diarrhea in young children. J Health Sci 2008, 17:S1255-S1261.
70. Sungkapalee T., Puntukosit P., Eunsuwan O., Theamboonlers A., Chongsrisawat V., Poovorawan Y. Incidence and clinical manifestations of rotavirus infection among children with acute diarrhea admitted at Buri Ram Hospital, Thailand. Southeast Asian J Trop Med Public Health 2006, 37(November (6)):1125-1131.
71. Wibulpolprasert S. Thailand health profile report 2005-2007 [cited 2009 October 11]; Available from: http://www.moph.go.th/ops/health_50/.
72. The World Bank. Country and lending groups 2011 [cited 2011 September 16]; Available from: http://data.worldbank.org/about/country-classifications/country-and-lending-groups%23Low_income.
73. Praditsitthikorn N., Teerawattananon Y., Tantivess S., Limwattananon S., Riewpaiboon A., Chichareon S., et al. Economic evaluation of policy options for prevention and control of cervical cancer in Thailand. Pharmacoeconomics 2011, 29(September (9)):781-806.
74. Department of Labour Protection and Welfare Ministry of Labour. Minimum wage rates (in Thai language). 2008 [cited 2010 October 21]; Available from: http://www.labour.go.th/news/file/minimumWage.pdf.